DPP4 and Insulin resistance: Another study showed that inhibition of dipeptidyl peptidase 4 (DPP4) skews KCs toward the anti-inflammatory M2 phenotype, thereby alleviating insulin resistance, steatohepatitis, and fibrosis in cholesterol high-fat diet models (Sakai et al., 2020).